[Hepatitis B vaccination with the plasma-derived Hevac-B Pasteur vaccine. A comparison of 2 populations: hospital personnel and hemodialysis patients].
A vaccination experiment using plasma-derived Hevac-B anti-hepatitis vaccine was conducted on two groups at high risk of HBV infection: hospital staff and hemodialyzed subjects. The qualities of the vaccine and the most important directions on how to use it rare briefly presented with a report on the protocol and the results of the vaccine cycle in both groups. It is concluded that the Hevac-B vaccine is efficacious in healthy subjects at risk, but gives an unsatisfactory result in immune deficient subjects, like those under haemodialysis.
Di Giandomenico
G
G
U.S.L. RM/35 - Ospedale di Anzio, Ambulatorio di Immunologia.
Di Giandomenico
F W
FW
Volterrani
A
A
D000328:Adult; D004341:Drug Evaluation; D006509:Hepatitis B / Q000517:prevention & control*; D006801:Humans; D007117:Immunization, Secondary; D007558:Italy; D008505:Medical Staff, Hospital; D008875:Middle Aged; D006435:Renal Dialysis; D012307:Risk Factors; D014761:Viral Hepatitis Vaccines / Q000008:administration & dosage*
D014761:Viral Hepatitis Vaccines
Vaccinazione anti epatite B con vaccino plasmaderivato Hevac-B Pasteur. Confronto tra due popolazioni: personale ospedaliero ed emodializzati.